871 related articles for article (PubMed ID: 26923637)
1. miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.
Han Y; Meng F; Venter J; Wu N; Wan Y; Standeford H; Francis H; Meininger C; Greene J; Trzeciakowski JP; Ehrlich L; Glaser S; Alpini G
J Hepatol; 2016 Jun; 64(6):1295-304. PubMed ID: 26923637
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
3. miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.
Ehrlich L; Hall C; Venter J; Dostal D; Bernuzzi F; Invernizzi P; Meng F; Trzeciakowski JP; Zhou T; Standeford H; Alpini G; Lairmore TC; Glaser S
Am J Pathol; 2017 Mar; 187(3):570-580. PubMed ID: 28087162
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.
Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T
Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203
[TBL] [Abstract][Full Text] [Related]
5. miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA.
Xu Z; Liu G; Zhang M; Zhang Z; Jia Y; Peng L; Zhu Y; Hu J; Huang R; Sun X
Cell Physiol Biochem; 2018; 48(6):2596-2606. PubMed ID: 30121648
[TBL] [Abstract][Full Text] [Related]
6. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day.
Yang X; Wood PA; Ansell CM; Quiton DF; Oh EY; Du-Quiton J; Hrushesky WJ
Chronobiol Int; 2009 Oct; 26(7):1323-39. PubMed ID: 19916834
[TBL] [Abstract][Full Text] [Related]
7. Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.
Huang CK; Aihara A; Iwagami Y; Yu T; Carlson R; Koga H; Kim M; Zou J; Casulli S; Wands JR
Cancer Lett; 2016 Sep; 380(1):153-62. PubMed ID: 27364974
[TBL] [Abstract][Full Text] [Related]
8. microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
Qiao P; Li G; Bi W; Yang L; Yao L; Wu D
BMC Cancer; 2015 Jun; 15():469. PubMed ID: 26077733
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
Liu B; Hu Y; Qin L; Peng XB; Huang YX
Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
[TBL] [Abstract][Full Text] [Related]
10. The effect of dexamethasone on clock gene mRNA levels in bovine neutrophils and lymphocytes.
Nebzydoski SJ; Pozzo S; Nemec L; Rankin MK; Gressley TF
Vet Immunol Immunopathol; 2010 Dec; 138(3):183-92. PubMed ID: 20807668
[TBL] [Abstract][Full Text] [Related]
11. Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression.
Wu C; Zhang J; Cao X; Yang Q; Xia D
Med Sci Monit; 2016 Jul; 22():2685-90. PubMed ID: 27472451
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
Chang W; Wang Y; Li W; Shi L; Geng Z
J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells.
Zhu H; Jiang X; Zhou X; Dong X; Xie K; Yang C; Jiang H; Sun X; Lu J
Liver Int; 2018 Jan; 38(1):125-135. PubMed ID: 28618167
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.
Liu Z; Jin ZY; Liu CH; Xie F; Lin XS; Huang Q
Int J Clin Exp Pathol; 2015; 8(5):4684-94. PubMed ID: 26191158
[TBL] [Abstract][Full Text] [Related]
16. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis.
Ma J; Weng L; Wang Z; Jia Y; Liu B; Wu S; Cao Y; Sun X; Yin X; Shang M; Mao A
Exp Cell Res; 2018 May; 366(2):103-113. PubMed ID: 29530475
[TBL] [Abstract][Full Text] [Related]
17. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
18. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
19. [Effects and mechanism of the circadian clock gene Per1 on the proliferation, apoptosis, cycle, and tumorigenicity in vivo of human oral squamous cell carcinoma].
Xiaojuan F; Kai Y; Hanxue L; Qin Z; Dan C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2016 Jun; 34(3):255-61. PubMed ID: 27526449
[TBL] [Abstract][Full Text] [Related]
20. MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression.
Li J; Tian F; Li D; Chen J; Jiang P; Zheng S; Li X; Wang S
FEBS Lett; 2014 Sep; 588(18):3491-500. PubMed ID: 25131931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
